Would you have Cutaneous Lupus Erythematosus when you have Multiple Myeloma?


Cutaneous lupus erythematosus is reported only by a few people with Multiple myeloma. We study 5 people who have Cutaneous lupus erythematosus and Multiple myeloma from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Multiple Myeloma

Multiple myeloma (cancer of the plasma cells) can be treated by Revlimid, Velcade, Dexamethasone, Zometa, Thalomid (latest reports from 152,878 Multiple myeloma patients)

Cutaneous Lupus Erythematosus

Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms) has been reported by people with rheumatoid arthritis, high blood pressure, psoriasis, crohn's disease, depression (latest reports from 1,586 Cutaneous lupus erythematosus patients).

On Oct, 23, 2016

5 people who have Multiple Myeloma and Cutaneous Lupus Erythematosus are studied.

Number of reports submitted per year:

Would you have Cutaneous lupus erythematosus when you have Multiple myeloma?

Gender of people who have Multiple Myeloma and experience Cutaneous Lupus Erythematosus *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Multiple Myeloma and experience Cutaneous Lupus Erythematosus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top co-existing conditions for these people *:

  • Prophylaxis (1 person, 20.00%)
  • Hypertension (1 person, 20.00%)
  • Chest Pain (1 person, 20.00%)
  • Back Pain (1 person, 20.00%)
  • Aortic Valve Replacement (1 person, 20.00%)

Most common drugs for these people *:

  • Velcade (3 people, 60.00%)
  • Phenprocoumon (1 person, 20.00%)
  • Dexamethasone (1 person, 20.00%)
  • Dalteparinnatrium (1 person, 20.00%)
  • Amiodarone Hcl (1 person, 20.00%)

Top symptoms for these people *:

  • Squamous Cell Carcinoma Of Skin (1 person, 20.00%)
  • Impaired Healing (1 person, 20.00%)
  • Disease Recurrence (1 person, 20.00%)
  • Actinic Keratosis (1 person, 20.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Cutaneous lupus erythematosus and Multiple myeloma?

Browse all symptoms of Multiple myeloma

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Cutaneous lupus erythematosus

Cutaneous lupus erythematosus

Other conditions that could case Cutaneous lupus erythematosus

Cutaneous lupus erythematosus

Related studies

Can you answer these questions?

More questions for: Multiple myeloma, Cutaneous lupus erythematosus

You may be interested in these reviews

More reviews for: Multiple myeloma, Cutaneous lupus erythematosus

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.